CD4 and cryptococcosis: After treatment of both cryptococcosis and underlying HIV, despite comparable CD4 counts, CRAG-positive individuals have a 12-month mortality rate approximately 3 times greater than CRAG-negative controls [5], suggesting that additional host immune factors, beyond that reflected by the CD4 count, may contribute to cryptococcosis susceptibility.